Article Data

  • Views 283
  • Dowloads 118

Original Research

Open Access

The correlation between expression of synuclein-γ, glucose transporter-1, and survival outcomes in endometrioid endometrial carcinoma

  • D. G. Hong1
  • N. Y. Park1
  • G. O. Chong1
  • Y. L. Cho1
  • I. S. Park1
  • M. J. Jeong2
  • J. Y. Park3
  • Y. S. Lee1,*,

1Gynecologic Cancer Center, Kyungpook National University Medical Center, Daegu

2Department of Mathematics, Korea Science Academy of Korea Advanced Institute of Science and Technology, Pusan

3Department of Pathology, Kyungpook National University Medical Center, Daegu (Republic of Korea)

DOI: 10.12892/ejgo340204 Vol.34,Issue 2,March 2013 pp.128-131

Published: 24 March 2013

*Corresponding Author(s): Y. S. Lee E-mail:


Purpose: To evaluate the correlation between immunohistochemical expression of synuclein-γ, glucose transporter-1, and survival outcomes in endometrioid endometrial carcinoma. Materials and Methods: A tissue microarray was constructed using formalinfixed, paraffin-embedded tissue that included 23 early and 18 advanced cases. The intensity and area of the immunohistochemical reactions were evaluated using the semi-quantitative scoring system. Results: Synuclein-γ expression was higher in the advanced stage, although it was not statistically significant (p = 0.51). Glucose transporter-1 was overexpressed in the advanced stage (p = 0.01). Synuclein-γ (score = 0 vs > 0) and glucose transporter-1 (score ≤ 7 vs > 7) did not show any differences in overall survival (p = 0.54, p = 0.48) and disease-free survival (p = 0.61, p = 0.14). Conclusion: In this study the expression of synuclein-γ and glucose transporter-1 were not considered to be a prognostic factor and were not related with survival outcomes in endometrioid endometrial carcinoma.


Endometrial carcinoma; Synuclein-γ; Glucose transporter-1.

Cite and Share

D. G. Hong,N. Y. Park,G. O. Chong,Y. L. Cho,I. S. Park,M. J. Jeong,J. Y. Park,Y. S. Lee. The correlation between expression of synuclein-γ, glucose transporter-1, and survival outcomes in endometrioid endometrial carcinoma. European Journal of Gynaecological Oncology. 2013. 34(2);128-131.


[1] Jemal A., Siegel R., Ward E., Hao Y., Xu J., Thun M.J.: “Cancer statistics”. C.A. Cancer J. Clin., 2009, 59, 225.

[2] Don S.: “Dizon; treatment options for advanced endometrial carcinoma”. Gynecol. Oncol., 2010, 117, 378.

[3] George J.M.: “The synucleins”. Genome Biol., 2002, 3, Reviews 3002. Epub 2001 Dec. 20.

[4] Lavedan C.: “The synuclein family”. Genome Res., 1998, 8, 871.

[5] Singh V.K., Zhou Y., Marsh J.A., Uversky V.N., Forman-Kay J.D., Liu J., Jia Z.: “Synuclein-gamma targeting peptide inhibitor that enhances sensitivity of breast cancer cells to antimicrotubule drugs”. Cancer Res., 2007, 67, 626.

[6] Zhou Y., Inaba S., Liu J.: “Inhibition of synuclein-gamma expression increases the sensitivity of breast cancer cells to paclitaxel treatment”. Int. J. Oncol., 2006, 29, 289.

[7] Airley R., Loncaster J., Davidson S., Bromley M., Roberts S., Patterson A. et al.: “Glucose transporter glucose transporter - 1 expression correlates with tumor hypoxia and predicts metastasisfree survival in advanced carcinoma of the cervix”. Clin. Cancer Res., 2001, 7, 928.

[8] Ito T., Noguchi Y., Satoh S., Hayashi H., Inayama Y., Kitamura H.: “Expression of facilitative glucose transporter isoforms in lung carcinomas: its relation to histologic type, differentiation grade, and tumor stage”. Mod. Pathol., 1998, 11, 437.

[9] Noguchi Y., Marat D., Saito A., Yoshikawa T., Doi C., Fukuzawa K. et al.: “Expression of facilitative glucose transporters in gastric tumors”. Hepatogastroenterology, 1999, 46, 2683.

[10] Haber R.S., Rathan A., Weiser K.R., Pritsker A., Itzkowitz S.H., Bodian C.S. et al.: “GLUT1 glucose transporter expression in colorectal carcinoma: a marker for poor prognosis”. Cancer, 1998, 83, 34.

[11] Bruening W., Giasson B.I., Klein-Szanto A.J., Lee V.M., Trojanowski J.Q., Godwin A.K.: “Synucleins are expressed in the majority of breast and ovarian carcinomas and in preneoplastic lesions of the ovary”. Cancer, 2000, 88, 2154.

[12] Morgan J., Hoekstra A.V., Chapman-Davis E., Hardt J.L., Kim J.J., Buttin B.M.: “Synuclein-gamma (SNCG) may be a novel prognostic biomarker in uterine papillary serous carcinoma”. Gynecol. Oncol., 2009, 114, 293.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time